|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Fixed-maturity securities, held-to-maturity, at amortized cost (fair value of $5,065,341 at June 30, 2026 and $5,137,267 at December 31, 2025) | ||||||||||||||||||||
| Fixed-maturity securities, available-for-sale, at fair value (amortized cost of $324,716,045 at June 30, 2026 and $296,738,055 at December 31, 2025) | ||||||||||||||||||||
| Equity securities, at fair value (cost of $13,598,454 at June 30, 2026 and $13,546,654 at December 31, 2025) | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Premiums receivable, net of allowance for credit losses of $80,779 at June 30, 2026, and $20,831 at December 31, 2025 | ||||||||||||||||||||
| Reinsurance receivables, net | ||||||||||||||||||||
| Prepaid reinsurance | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Loss and loss adjustment expense reserves | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Advance premiums | ||||||||||||||||||||
| Reinsurance balances payable | ||||||||||||||||||||
| Deferred ceding commission revenue | ||||||||||||||||||||
| Accounts payable, accrued expenses and other liabilities | ||||||||||||||||||||
| Debt, net | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Debt, net (current $1,335,349 and long-term $2,465,799 at June 30, 2026, current $1,296,900 and long-term $3,143,227 at December 31, 2025) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and Contingencies (Note 11) | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Preferred stock, $0.01 par value; authorized 2,500,000 shares | ||||||||||||||||||||
| Common stock, $0.01 par value; authorized 20,000,000 shares; issued 16,018,235 shares at June 30, 2026 and 15,921,651 shares at December 31, 2025; outstanding 14,474,664 shares at June 30, 2026 and 14,397,526 shares at December 31, 2025 | ||||||||||||||||||||
| Capital in excess of par | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Stockholders' equity before treasury stock | ||||||||||||||||||||
| Treasury stock, at cost, 1,543,571 shares at June 30, 2026 and 1,524,125 at December 31, 2025 | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
